Harbour Investments Inc. Has $265,000 Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Harbour Investments Inc. raised its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,389 shares of the pharmacy operator’s stock after purchasing an additional 1,165 shares during the period. Harbour Investments Inc.’s holdings in Walgreens Boots Alliance were worth $265,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in WBA. Charles Schwab Investment Management Inc. increased its holdings in shares of Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after buying an additional 3,329,857 shares in the last quarter. Swedbank AB increased its holdings in shares of Walgreens Boots Alliance by 45.3% during the fourth quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator’s stock worth $5,559,000 after buying an additional 185,762 shares in the last quarter. PNC Financial Services Group Inc. increased its holdings in shares of Walgreens Boots Alliance by 23.4% during the third quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator’s stock worth $3,050,000 after buying an additional 64,586 shares in the last quarter. Sunbelt Securities Inc. increased its holdings in shares of Walgreens Boots Alliance by 82.8% during the third quarter. Sunbelt Securities Inc. now owns 139,377 shares of the pharmacy operator’s stock worth $1,249,000 after buying an additional 63,149 shares in the last quarter. Finally, Merit Financial Group LLC acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $326,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on WBA. Bank of America boosted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Truist Financial reduced their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their price objective for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Finally, StockNews.com began coverage on shares of Walgreens Boots Alliance in a research note on Tuesday. They issued a “hold” rating on the stock. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $10.59.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $11.10 on Friday. The stock has a market capitalization of $9.59 billion, a P/E ratio of -1.08, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. The firm’s fifty day simple moving average is $10.96 and its two-hundred day simple moving average is $9.82. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business’s revenue was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.66 EPS. As a group, analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.